What Causes High Lipoprotein(a)? Why Lp(a) Runs High

What Causes High Lipoprotein(a)? Why Lp(a) Runs High

This page is educational and not medical advice. What follows covers where a high number comes from, what the particle does inside an artery wall, what can move a reading apart from inheritance, how the result is reported, and when to bring it to a clinician.

What is Lp(a), in short?

Lp(a) is a cholesterol-carrying particle built on the same backbone as LDL, with one extra protein, apolipoprotein(a), bonded to the apolipoprotein B on its surface 1. That extra protein is what separates it from ordinary LDL, and it is why the marker needs its own test rather than appearing inside a standard lipid result. The full definition, how the sample is collected and processed, the ranges and how to read a single value all sit on the Lipoprotein (a) biomarker page, which is the parent guide for this marker. This page stays on one narrower question, why some people carry a high level at all. A clinician decides what any individual result reflects for that person.

Why does Lp(a) run high in some people?

A high Lp(a) comes mainly from the copy of the LPA gene you inherited, not from how you eat, train or sleep. Research suggests that Lp(a) concentration is largely genetically determined and behaves as a causal risk factor for atherosclerotic cardiovascular disease rather than as a passive bystander 2.

The gene detail matters, because it explains how two people eating the same food and doing the same training can sit at opposite ends of the distribution. The LPA gene contains a stretch of DNA repeated a variable number of times, called kringle IV type 2, and the number of copies differs from person to person and between a single person's two gene copies 1. Research suggests that a smaller apolipoprotein(a) protein, built from fewer of these repeats, is associated with a higher circulating Lp(a) concentration 1.

Because each parent contributes one copy of the gene and each copy contributes its own output, your level is the sum of two inherited settings rather than a score for your habits. That also explains the stability people notice when they retest. Research suggests that Lp(a) concentration stays relatively stable within an individual over time, which is one reason a single careful measurement carries weight 3.

Ancestry shows up in the data as well. Research suggests that the distribution of Lp(a) differs between population groups, with higher concentrations reported in people of African ancestry 2. That is a statement about group distributions, not a prediction about any one person, and it does not change how a clinician reads your own number against the range printed on your report.

Does a high level run in families?

Yes. Lp(a) is inherited, so a high result in one person is also information about parents, siblings and children. Research suggests that Lp(a) is a genetically determined and prevalent risk factor for atherosclerotic cardiovascular disease, and the American Heart Association scientific statement describing it addresses the testing of relatives of people found to carry high levels 2.

In practice, the family pattern that leads a clinician to look at this marker is heart disease or stroke at a young age in a parent, sibling or child, or a known inherited lipid condition running through the family tree. People with familial hypercholesterolemia sit in that second group, and the two problems can travel together. Research suggests that, in people with familial hypercholesterolemia, a raised Lp(a) adds to cardiovascular risk on top of the high LDL cholesterol that defines the condition 3.

Two practical points follow. The first is that a result can reframe a family story that previously looked like bad luck, by giving a name to something that was already being passed down. The second is that your own value does not tell you which relative carries what. Each person's level is their own, set by the gene copies they received, and a clinician decides whether testing a relative is appropriate and what to do with the answer. If you are the first person in your family to see this number, bring it to the conversation rather than drawing conclusions about anyone else.

What does it mean when lipoprotein(a) is high?

A high lipoprotein(a) means more of this one particle is circulating, and the practical meaning is a shift in long-term cardiovascular risk rather than a statement about how you are today. Research suggests that higher Lp(a) is associated with coronary heart disease, myocardial infarction, ischaemic stroke, peripheral arterial disease and calcific aortic valve stenosis 4.

Two qualifiers keep that in proportion. The first is that the relationship runs along a gradient. Research suggests that risk rises continuously as Lp(a) concentration rises, rather than switching on at a single line in the sand 5. A value a little above the printed range and a value far above it are not the same conversation.

The second is that Lp(a) is one input among several. Blood pressure, apolipoprotein B, smoking status, glucose handling, kidney function, sleep and family history all sit inside the same risk picture, and several of those respond to changes that Lp(a) itself does not. A person with a high Lp(a) and otherwise well-controlled numbers is in a different position from a person with a high Lp(a) and three other markers sitting outside their printed ranges.

What the number cannot do is tell you when anything will happen, or whether anything will happen at all. A result outside the range printed on your lab report does not identify a condition. It is a number a clinician reads next to the rest of your biology before deciding whether anything changes, and treatment decisions belong to a licensed provider.

How does the particle affect arteries and the aortic valve?

Lp(a) can enter the artery wall and be retained there in the way LDL is, and it also carries extra cargo and an unusual protein, which gives it more than one route to do damage 7. Those strands are worth separating, because they explain why this particle gets attention out of proportion to how much of your cholesterol it carries.

The cargo comes first. Research suggests that Lp(a) is a preferential carrier of oxidized phospholipids, which drive inflammatory signalling in the vessel wall 6. That inflammatory signal is part of why the particle is studied separately from the cholesterol it transports.

The protein comes second. Research suggests that apolipoprotein(a) shares structural similarity with plasminogen, the protein the body uses to break down clots, which may interfere with the clot-dissolving process 1. A particle that can both sit in a plaque and influence clot breakdown is working on two fronts at once.

The aortic valve comes third. Research suggests that Lp(a) is associated with calcific aortic valve disease, with the oxidized phospholipid pathway implicated in the stiffening and calcification of the valve leaflets 7. The European Atherosclerosis Society consensus statement covers aortic stenosis alongside atherosclerotic disease for that reason 3.

None of this is visible or felt. It accumulates quietly across decades, which is exactly why a blood test is the only way the marker enters the conversation, and why the result is read as a long-horizon input rather than a description of this week.

What can push the number up besides genes?

Inheritance sets the baseline, and a short list of medical situations can move a reading around that baseline. Research suggests that Lp(a) behaves in part as an acute phase reactant, so a sample drawn during an acute illness or soon after a cardiovascular event can read higher than that person's steady state 8. That is one reason a clinician looks at when the blood was drawn before deciding what a surprising number means.

Kidney function is the second. Studies indicate that Lp(a) concentrations can be higher in people with kidney disease, including nephrotic syndrome 8.

Some medicines move lipid results in one direction or another. Ask your prescriber about yours rather than stopping, starting or changing anything on your own, because the person who prescribed a medicine is the one who can weigh its effect against the reason it was prescribed.

What is striking about this list is how short it is, and how modest the movements are next to the spread that inheritance produces. Two people can differ many times over in Lp(a) because of the gene copies they carry, and nothing on this list closes a gap of that size. That is the core of the answer to why Lp(a) runs high. It runs high because of how it was built, with circumstances nudging the dial rather than setting it.

Why do diet, exercise and weight loss move other lipids more than this one?

Because the LPA gene governs how much apolipoprotein(a) the liver makes, and that production line is not fed by dietary cholesterol, body fat or training volume in the way LDL cholesterol and triglycerides are. Research suggests that lifestyle change has limited effect on Lp(a) concentration 2.

That is a frustrating sentence to read if you have spent a year rebuilding your habits and watched other markers respond. It is not an argument for doing nothing, for two reasons.

The first is that the rest of the risk picture does move. Blood pressure, apolipoprotein B, triglycerides, glucose handling, body composition and smoking status all respond to sustained change, and they all sit in the same arteries as the Lp(a) particles. A fixed marker alongside a set of improving ones is a different situation from a fixed marker alongside a set of worsening ones.

The second is that clinicians work with total risk rather than one line on a report. A known high Lp(a) can change how closely the modifiable parts of the picture are watched, and how early that conversation starts. What a licensed provider can consider when the number is high is a clinical judgement made with the whole person in view, and treatment decisions belong to a licensed provider who evaluates whether any option is appropriate.

How is a high result reported, and what range is used?

Lp(a) is reported as a number with units, next to a reference range set by the laboratory that ran the sample, and FitScript publishes its own optimal range alongside it.

Lipoprotein (a) Range
FitScript optimal range 0 to 14 mg/dL
The lab's own reference range As printed on your lab report

FitScript's optimal range is an optimization target, not a diagnostic cut-off. Reference ranges vary by lab, age and sex, so read the range printed on your own report rather than a number lifted from an article.

Units are the detail that confuses people comparing results. Laboratories report Lp(a) either as a mass concentration in mg/dL or as a particle concentration in nmol/L. Research suggests that mass-based and molar results are not directly interchangeable, because the apolipoprotein(a) protein varies in size between people and that variation affects mass measurements 9. A conversion done at the kitchen table can therefore mislead, and two numbers from two laboratories can look different when the underlying biology has not changed.

The reading sequence stays the same whatever the units. Note the value, note the range printed beside it, and note when the blood was drawn. A value outside the printed range is worth discussing with a clinician, who decides what it reflects for you and whether anything follows from it.

Does a high Lp(a) change how your other cholesterol numbers read?

It can, because this particle is counted inside measures you may already be tracking. Research suggests that the cholesterol carried within Lp(a) particles is included in a standard LDL cholesterol result, so in a person with a high Lp(a), part of the reported LDL figure comes from this particle 8.

Apolipoprotein B works the same way. Each Lp(a) particle carries one apolipoprotein B-100 molecule in addition to its apolipoprotein(a) 1, so Lp(a) particles are counted within an apolipoprotein B measurement rather than sitting outside it.

The practical consequence is that two people with identical LDL cholesterol can be carrying different particle mixes, and the difference is invisible unless Lp(a) has been measured. That is one reason a clinician can want this number on the page when reading a lipid panel, rather than reading the panel in isolation. Research suggests that Lp(a) carries risk information beyond standard lipid measures 5.

None of this makes your other numbers wrong. It makes them easier to interpret correctly. A clinician reading an LDL cholesterol result next to a known Lp(a) can see how much of the total is coming from a particle that behaves differently, and that context belongs to the clinician, not to a calculation you run on your own.

How is it measured, and does the test need repeating?

Lp(a) is measured on a blood sample collected and processed by the laboratory, and the European Atherosclerosis Society consensus statement advises measuring Lp(a) at least once in each adult's lifetime 3. The reasoning behind a once-in-a-lifetime approach is the stability described earlier. Research suggests that concentrations stay relatively stable within an individual across time, so a careful measurement gives a long-lasting piece of information 3.

Method matters for comparison. Research suggests that assay standardization and the variable size of apolipoprotein(a) complicate the comparison of results produced by different methods 9. Where you can, keep repeat measurements at the same laboratory and in the same units, so that two numbers are actually comparable.

There are situations where a clinician decides to repeat the test. A first sample drawn during an acute illness or soon after a cardiovascular event can read above the person's steady state 8. An unexpected value, a change of laboratory, or a change of units can also prompt a second look. That decision belongs to the clinician ordering the test, not to a rule from an article.

If other tests are drawn at the same visit, ask the laboratory or the clinician who ordered them whether any preparation is needed, and follow the instructions you were given for that draw.

What other markers are worth checking alongside it?

Lp(a) is read as part of a wider lipid and cardiovascular picture, because no single particle describes an artery on its own. The markers a clinician can want on the same page include the following.

The point of grouping these is not to collect data for its own sake. It is that Lp(a) adds to the picture instead of replacing part of it. Research suggests that Lp(a) carries information beyond standard lipid measures 5, which means the useful question is what the whole set says together. A clinician reads them as a group and decides what follows.

Which tests can help?

FitScript's Heart Health panel is one place a reader looking into this topic can see lab testing laid out. FitScript membership includes 150+ biomarkers tested per year, with interpretation from Atlas, FitScript's AI health advisor. A licensed clinician reviews the results and decides what they mean and what to do next.

Which symptoms need emergency care, and which need a clinic visit?

A high Lp(a) produces no symptoms of its own, so symptom decisions rest on what you feel, never on the number.

Call 911 or go to the emergency department for any of these.

These are reasons to book a clinic visit instead.

Discuss your results and any treatment with a clinician or licensed provider, who decides what your numbers reflect and what comes next.

Key takeaways

If you want the next-step side of this question, the companion guide on how to lower lipoprotein a covers what can and cannot change the number, and what a licensed provider weighs when a result sits above the printed range.

References

  1. Structure, function, and genetics of lipoprotein (a). Journal of Lipid Research, 2016.
  2. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology, 2022.
  3. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. European Heart Journal, 2022.
  4. Lipoprotein(a) and cardiovascular disease. Lancet, 2024.
  5. Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review. JAMA Cardiology, 2022.
  6. Lipoprotein(a) and cardiovascular disease. The Biochemical Journal, 2024.
  7. Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment. Molecules, 2023.
  8. A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies. Journal of the American College of Cardiology, 2017.
  9. Lipoprotein(a) and Cardiovascular Disease. Clinical Chemistry, 2021.

Common questions

Is a high Lp(a) inherited from one parent or both?

Both gene copies count. You inherit one copy of the LPA gene from each parent, and each copy contributes to the level you carry, so your number is the sum of two inherited settings. Whether relatives should be tested is a decision for their clinician.

Can diet and exercise bring a high Lp(a) down?

Lp(a) is set mainly by the gene you inherited, so the habit changes that move LDL cholesterol and triglycerides do not move this marker in the same way. That does not make the rest of your routine pointless, because blood pressure, other lipids, body composition and glucose handling all respond to it. What to do about a high Lp(a) is a decision for a licensed provider.

Does a high Lp(a) result mean I will have a heart attack?

No. A result outside the range printed on your lab report does not identify a condition and does not predict an event for any one person. It is one input a clinician reads alongside your blood pressure, other lipids, family history and overall health.

How many times does Lp(a) need to be measured?

The level stays fairly steady in an adult, so a single careful measurement can give a clinician what they need. A repeat can be considered when the first sample was drawn during an acute illness, when the value was unexpected, or when a different laboratory or a different unit makes two results hard to line up. Your clinician decides.

Why does my report show nmol/L when someone else's shows mg/dL?

Laboratories report Lp(a) either as a mass concentration in mg/dL or as a particle concentration in nmol/L. The two are not interchangeable, because the apolipoprotein(a) protein varies in size from person to person. Compare results from the same laboratory in the same unit where you can, and ask the clinician reading your report.

Should my children or siblings be tested?

Because Lp(a) is inherited, a high result in one person raises the question for first-degree relatives. Whether and when a relative is tested is a clinical decision made with their own history and family history in view. Raise it with their clinician rather than arranging it on assumption.

Does the Lp(a) test need fasting?

Ask the laboratory or the clinician who ordered it. Other tests drawn at the same visit can carry their own preparation instructions, and the lab processing the sample is the reliable source for those. Follow the instructions you were given for that draw.

What should I do if my Lp(a) is above the range printed on my report?

Bring it to a clinician, who decides what the value reflects for you and whether anything changes. Do not start or stop any medicine on your own, and ask your prescriber about the medicines you already take. Chest pain or pressure, trouble breathing, or sudden weakness on one side means call 911 or go to the emergency department.

Related reading